Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/44977| Title: | Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up | Authors: | CUPPENS, Kristof Baas, P. Wiesweg, M. Du Pont, B. Ploenes, T. Theegarten, D. Aigner, C. Hartemink, K. MAES, Brigitte Pat, K. Schuler, M. |
Issue Date: | 2024 | Publisher: | ELSEVIER SCIENCE INC | Source: | Journal of thoracic oncology, 19 (10) , p. S9 | Keywords: | neoadjuvant;LAG-3;relatlimab | Document URI: | http://hdl.handle.net/1942/44977 | ISSN: | 1556-0864 | e-ISSN: | 1556-1380 | ISI #: | 001337925600014 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.